US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
AdAlta Limited (1ADOA) 銘柄情報

AdAlta Limited (1ADOA)

0.001

0.00

(0.00%)

終了 7月4日 3:00PM

AdAlta Limited (1ADOA) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.001

( - )

買値

0.001

売値

0.001

出来高

0.00

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

0.001

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 3,393,536

発行済株式数

2,975,919,019

配当利回り

PER

-1.02

1 株当たり利益 (EPS)

-0

歳入

608.07k

純利益

-4.36M

AdAlta Limited, a clinical-stage biotechnology company, discovers and develops protein and cell-based therapeutics by its i-body platform in Australia. Its lead product is AD-214, which is in Phase II clinical trial for the treatment of fibrosis diseases, including idiopathic pulmonary fibrosis, eye... AdAlta Limited, a clinical-stage biotechnology company, discovers and develops protein and cell-based therapeutics by its i-body platform in Australia. Its lead product is AD-214, which is in Phase II clinical trial for the treatment of fibrosis diseases, including idiopathic pulmonary fibrosis, eye fibrosis, and fibrosis diseases of the liver, skin and kidney, as well as for the treatment of age-related macular degeneration. It has discovered WD-34 for the multiple malaria species, Babesia, and Toxoplasma in collaboration with La Trobe University. The company was incorporated in 2006 and is based in Camberwell, Australia. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.adalta.com.au

本社

Camberwell, Australia

設立

2026

AdAlta Limited is listed in the sector of the オーストラリア証券取引所 with ticker 1ADOA. The last closing price for AdAlta was AUD0. Over the last year, AdAlta shares have traded in a share price range of AUD 0.00 to AUD 0.00.

AdAlta currently has 2,975,919,019 shares in issue. The market capitalisation of AdAlta is AUD2.98 million. AdAlta has a price to earnings ratio (PE ratio) of -1.02.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

1ADOA - Frequently Asked Questions (FAQ)

What is the current AdAlta Limited share price?

The current share price of AdAlta Limited is AUD 0.001

How many AdAlta Limited shares are in issue?

AdAlta Limited has 2,975,919,019 shares in issue

What is the market cap of AdAlta Limited?

The market capitalisation of AdAlta Limited is AUD 2.98M

What is the 1 year trading range for AdAlta Limited share price?

AdAlta Limited has traded in the range of AUD 0.00 to AUD 0.00 during the past year

What is the PE ratio of AdAlta Limited?

The price to earnings ratio of AdAlta Limited is -1.02

What is the cash to sales ratio of AdAlta Limited?

The cash to sales ratio of AdAlta Limited is 19.58

What is the registered address of AdAlta Limited?

The registered address for AdAlta Limited is 697 Burke Road, Camberwell, Victoria, 3124

What is the AdAlta Limited website address?

The website address for AdAlta Limited is www.adalta.com.au

theRupertPupkin

theRupertPupkin 5分前

Posted on behalf of Corcel Exploration -
From 1940 to 1963, the Yuma Mine in west-central Arizona produced 8,600 tons at 2.3% copper (CRCL.c, CRLEF). It's one dot on the 100%-owned Yuma King project: ~3,200 hectares (515 claims) in the Ellsworth Mining District, ~150 km northwest of Phoenix.

FormalMHRAconsultant

FormalMHRAconsultant 5分前

I'm guessing no one, including the company, the regulators, and even (especially?) the shorts thought that applying Individual Patient Data (IPD) would offer even improved statistical data. The thought of moving forward with this project was likely to achieve a match, and back up the MAIC.

Goats'nCrows

Goats'nCrows 6分前

So is the living Reddit meme going to tell us "Biotech is hard."?

beartrap12

beartrap12 6分前

Dr. Bosch concludes on p.15 that the survival extension analysis shown through Propensity Score Matching was significantly better, pretty much double, the original analysis on all of the many tests run by independent analysis:

PSM analyses using Individual Patient Data (IPD) for preci

Blish

Bloomberg:
America Runs on Natural Gas: Fuel Set to Surpass Oil as US Top Energy Source by 2030. By the end of the decade, natural gas will likely surpass oil for the first time as the top energy source for the US.

Forensics888

Forensics888 7分前

RE: What's the bottom line for sending in Pulte to dig up dirt ?

It's his job as a Regulator of F&F. With that "title" comes huge responsibilities. I seriously doubt he would ignore or play dirty with F&F and risk his family's name in housing etc.

No different than a

GoodGuyBill

GoodGuyBill 9分前

I asked ChatGPT the following question, regarding the UK BNOS 2026 NWBO presentation slides:
Please provide an extremely detailed, thorough analysis of the UK BNOS slides via the following link: Try this link: https://nwbio.com/wp-content/uploads/NWBT-BNOS-slides-7-3-26MB-LP-final.pdf.

ErnieBilco

ErnieBilco 11分前

Holding for the big money. Had a nice week on my Rolls Royces selling 100 share blocks - next one is set to go at $21 I really think $25 - $30 is where it will wind up. Then I sold 5000 shares of SHAZW(all they gave me) total cost $9.45 including commish and sold for $1598.xx

Doubt

Renorocker

Renorocker 12分前

Again, OTC has made R/S infamous as it usually means the stock death certificate.
With a growing flourishing company R/S at a certain share price to get the OS structure in check = I am all for it. Bullish as F**K

US Market News

US Market News 13分前

Neugebauer Suspends Current Proxy Campaign While Leading with About 70% of Votes Recorded, Following Judge's Inexplicable Last-minute Recusal That Throws off Timeline for Strategic Process; Reaffirms Confidence in Fermi's FutureJuly 3, 2026 1:33 PM
PR Newswire (US)

Denisk

Denisk 15分前

Thank you for this very informative answer.
Based on the volume of trading on June 26, 30 and July 1st, you may assume that of these ATM trading took place.

Renorocker

Renorocker 15分前

That is why my response is hence, needs to grow organically.

Whalatane

Whalatane 17分前

Fantastic. congrats

Kiwi

FeMike

FeMike 17分前

Any sign of NWBO amplifying the results?

I would be absolutely stunned if NWBO issued a PR discussing the results. Our best hope is likely a news outlet picking it up and publishing something.

That being said, if NWBO put out a PR with an attention grabbing headline som

chazzy1

chazzy1 19分前

Rapz, would you mind explaining what you mean by your rather cryptic statement:
"Wishful thinking indeed and at this stage of the VP game not reasonable at all. Any idea of settlement by year end is out the window. See you all next June!"
Thanks!

nowwhat2

nowwhat2 19分前

https://investorshub.advfn.com/uimage/uploads/2026/7/3/coksxGUTSI_WE_FEEL_GOOD_3.jpg

I should be in advertising
.

ErnieBilco

ErnieBilco 19分前

Not yet currently 660% showing but then again it's all profit since I sold enough for 200% wayyyyyy long ago. My cost basis is $2.406

manibiotech

manibiotech 21分前

I will likely buy more this week after a long time

badgerkid

badgerkid 23分前

So many investors may be missing the boat on IOVA. Despite its early missteps, it may be time to look again at taking a postion in IOVA:

https://simplywall.st/community/narratives/us/pharmaceuticals-biotech/nasdaq-iova/iovance-biotherapeutics/ismg0jwg-why-i-think-iovance-is-undervalu

newflow

newflow 23分前

Any update from PAC on the DE docket or at DTC?.
Gemini's Response:
As of today, **July 1, 2026**, there are still **no new active changes, public distribution notifications, or sudden judicial updates** on the Delaware Court of Chancery docket or from the Depository Trust Company (DTC

Timing101

Timing101 23分前

I always find it interesting when folks ask "how do I find" a contact, person, CEO, Marketing, email, phone number , history , DD , filings or trying to verify what
is said here instead of just doing the following.
a. Google the person
b. Google the filing
c. Look a

Whalatane

Whalatane 25分前

Are U up about 10X on this ??

Kiwi

Whalatane

Whalatane 25分前

Karen Firestone from CNBC ..ex Fidelity biotech fund manager I think
Karen Firestone (Amylyx Board Member): She is the co-founder, CEO, and Chairman of Aureus Asset Management.
She sits on the Amylyx Board as a member of both the Audit and the Nominating and Corporate Governance comm

sentiment_stocks

sentiment_stocks 26分前

Interesting, too, that using the MAIC actually underestimated the results, erring on the side of extreme caution in presenting the results.

I'm guessing no one, including the company, the regulators, and even (especially?) the shorts thought that applying Individual Patient Data (IPD)

ErnieBilco

ErnieBilco 26分前

Sounds like a winner to me.

BNP Paribas Issuance

Great Northern Minerals

Jpmorgan Mid Capital Inv...

Taiwan Semiconductor Man...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。